Introduction {#s1}
============

The precise spatial and temporal regulation of neuron maturation and synapse formation is crucial to ensure the fidelity of neural circuits. Many genes have been identified that regulate the initial steps of neuron maturation, including neuron fate and neurite development ([@bib6]; [@bib11]; [@bib45]). However, we know little about how these processes contribute to the emergence of ordered connectivity. In part, this is because many neurons form a large number of synapses, and these synapses are broadly distributed along the neuron. This makes it difficult to resolve the cellular and molecular drivers of these events. To solve this problem, we use the outer retina since it is one of the few regions in the mammalian central nervous system (CNS) where neuronal cell types and their basic connectivity are known ([@bib47]; [@bib9]; [@bib51]). In adult animals, outer retina synapses are localized in a thin band known as the outer plexiform layer (OPL) which consists of sublamina comprised of cone and rod synapses. Because each photoreceptor forms connections at one large distal location, the relationship between the structure and maturation of both pre and postsynaptic neurons relative to their connectivity can be directly examined.

OPL development begins after birth and involves interactions between four neuron types: presynaptic rods and cones, and postsynaptic bipolar and horizontal cells ([@bib13]). Cones and horizontal cells are the earliest born neurons in this circuit (\~E12-E17), and they are the first to form contacts in the emerging OPL. Newborn cones extend axons (P0-P5), and in concert, horizontal cells restrict their arbors to form the horizontal structure for which they are named. These contacts coincide with displacement of nuclei from the cell-free nascent OPL, which is visible by P5. In parallel, synapse-specific proteins are trafficked to cell terminals, corresponding with the onset of synapse formation. OPL sublamination of rod and cone synapses begins at P14, and the OPL is mature by P30 ([Figure 1A](#fig1){ref-type="fig"}, [@bib40]; [@bib12]; [@bib43]; [@bib48]). These events generally mirror those of other laminated CNS regions, such as the cerebellum, where neurons remodel together to give rise to ordered connectivity ([@bib37]). However, in the outer retina, as in the brain, fundamental questions remain: 1) what are the pathways that instruct synapse layer emergence; 2) how does the structure of each neural partner impact the development and connectivity of the other; and 3) how does neurite patterning influence the localization of nascent synapse proteins that may instruct ordered connectivity?

![LKB1 is required for outer plexiform layer formation.\
([**A**]{.smallcaps}) Schematic of outer plexiform layer (OPL) development from P3 to P14. The outer retina contains developing rods (yellow) and cones (green) that extend axons beginning at P1. Cones form contacts with horizontal cell interneurons (blue) at P3, where nascent synapse patches emerge at sites of contact (red circles), followed by synaptogenesis beginning at P5. This corresponds with OPL formation. Rods begin to form synaptic connections with horizontal cells by P8, and bipolar cells also begin to become integrated at this time (orange, rod bipolars; dark green, cone bipolars). Ribbon synapse formation is complete and OPL sublamination begins by P14. (ONBL, outer neuroblast layer; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer). (**B--D**) In control animals, the nascent OPL is first visible at P3 when it appears as small discontinuous gaps in the nuclear staining (DAPI, grey; arrowheads point to patches). These patches are distinct from gaps caused by horizontal cell bodies (magenta stars). In Lkb1-Ret animals, these OPL patches are small and located closer to the apical surface (**B**) and are reduced in number (**C,** n = 322 control cells and n = 252 Lkb1-Ret cells). N = 4 control and N = 4 Lkb1-Ret animals. At P5, nascent patches converge in control animals to generate a single continuous layer, forming the OPL. In Lkb1-Ret animals, the OPL was discontinuous and patches were misaligned and located closer to the apical surface (**D** n = 487 control cells and n = 339 Lkb1-Ret cells). This resulted in a marked decreased in total OPL area (**E**). N = 4 control and N = 8 Lkb1-Ret animals. Scale bars = 25 µm. Data are represented as a distribution of the distance of patches from the apical surface (**B,D**, \*\*\*p\<0.001, unpaired two-tailed Student's *t* test) or as the mean ± the s.e.m. (**E,** \*\*p\<0.01, non-parametric Mann-Whitney Rank Sum U-test).](elife-56931-fig1){#fig1}

To begin to resolve these questions, we focused on the serine/threonine kinase LKB1 (Liver Kinase B1, also called STK11 or Par4; encoded by *Stk11*). LKB1 regulates 14 kinases of the AMPK subfamily (AMPKα1/α2, SAD-A/B, NUAK1/2, SIK1-3, MARK1-4 and SNRK, [@bib34]; [@bib25]) and has cell-specific roles in polarity, neuron maturation, and axon formation ([@bib30]; [@bib52]; [@bib4]; [@bib16]). However, it is unknown whether or how LKB1-driven axon emergence impacts synapse localization. Given its high levels of expression in the retina ([@bib46]), we asked whether LKB1 may participate in programing outer retina connectivity and if these alterations might inform the cellular and molecular processes that drive synapse layer emergence. We show that loss of LKB1 delays formation of the OPL. This defect is accompanied by abnormal horizontal cell neurite restriction, with apical and basal processes that extend beyond the nascent synapse region. In concert, LKB1 mutants showed abnormal cone axon extension, and mislocalized axons were contacted by aberrant horizontal cell processes. Cone axon extension deficits were accompanied by specific defects in synaptic protein localization. In particular, we found that RIBEYE and VGLUT1 accumulated in the somas of LKB1 mutant cones and failed to properly reach the axon terminal. Misplaced synapse proteins were contacted by ectopic horizontal cell neurites. Together, these data suggest a model in which LKB1-mediated presynaptic axon extension and postsynaptic neurite refinement are coordinately required for precisely refining neuron structure and synapse protein localization.

Results {#s2}
=======

LKB1 regulates the timing of synapse layer emergence {#s2-1}
----------------------------------------------------

In control animals the nascent OPL first appears as small discontinuous patches at postnatal day 3 (P3), where horizontal cell neurites and cone terminals begin to form contacts. These patches begin to align and exclude the dense nuclei that populate the outer retina at P5. A single cell-free OPL layer forms as patches fully converge by P8 and the cellular boundaries of the ONL and INL become defined ([Figure 1A](#fig1){ref-type="fig"}). Correspondingly, we found that the levels of *Stk11* mRNA are highest in early development at P5 when synapses begin to emerge ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), with expression present in both inner and outer retina. To determine the role of LKB1 in the emergence of synaptic connectivity we generated full retina LKB1 knockout mice using the conditional allele *Stk11^F/F^* (previously called *Lkb1^F/F^,* [@bib3]) and the *Vsx2-cre* line (previously called *Chx10-cre,* [@bib44]) that expresses *Cre* in embryonic retinal progenitors to generate *Stk11^F/F^; Vsx2-Cre* animals. This line is hereafter referred to as Lkb1-Ret. Defects in LKB1 mutant retinas became apparent as the synapse layer began to emerge. While control animals displayed nuclei-free patches at P3 that are localized 39.1 ± 0.3 µm away from the apical side of the outer retina, in Lkb1-Ret mice OPL patches were small and difficult to visualize ([Figure 1B](#fig1){ref-type="fig"}), displaced closer to the apical retinal surface relative to control mice (29.6 ± 0.4 µm away, *p*\<0.0001), and reduced in number (40.1% reduction, *p*=0.0286, [Figure 1C](#fig1){ref-type="fig"}). At P5, these patches converged in control animals to form a single layer 54.1 ± 0.2 µm away from the apical surface of the retina, forming the OPL ([Figure 1B, D](#fig1){ref-type="fig"}). In contrast, the outer retina synapse layer was largely absent from Lkb1-Ret animals at this time point, appearing instead as discontinuous regions that were misaligned and located closer to the apical retina surface (36.2 ± 0.3 µm away, *p*\<0.0001, [Figure 1B, D](#fig1){ref-type="fig"}). These defects were accompanied by a 56.0% reduction in OPL area (*p*=0.004; [Figure 1E](#fig1){ref-type="fig"}).

We next examined OPL segregation, which occurs as nuclei become excluded from the synaptic layer and migrate into the outer and inner nuclear layers. To define the borders of the OPL, we first stained with DAPI to visualize nuclei. The OPL is precisely segregated at P8 in control animals, and nuclei are absent from the OPL ([Figure 2A](#fig2){ref-type="fig"}). In contrast, Lkb1-Ret animals display mislocalized nuclei within the OPL, with an 85.6% increase in ectopic nuclei (p=0.0294, [Figure 2A--B](#fig2){ref-type="fig"}). To visualize how these defects impacted neuron segregation, we labeled rods and bipolar cells whose nuclei reside at the upper and lower OPL boundaries. In control animals, cellular boundaries are clearly defined with rods appropriately localized to the ONL and bipolars localized to the INL ([Figure 2C](#fig2){ref-type="fig"}). In contrast, Lkb1-Ret animals displayed defects in rod neuron segregation. This resulted in some rod nuclei remaining below the nascent OPL and a 57.8% reduction in total OPL area (p=0.0286, [Figure 2C--D](#fig2){ref-type="fig"}). These alterations do not appear to be due to differences in neuron numbers, as both pre and postsynaptic outer retina neuron populations are present in equal numbers in LKB1 mutants ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). These data indicate that LKB1 coordinately regulates OPL emergence and nuclear segregation.

![The outer plexiform layer is disorganized in LKB1 mutant animals.\
(**A-B**) The OPL was visualized in Lkb1-Ret animals and control littermates at P8 following staining with DAPI. The OPL of Lkb1-Ret animals contains ectopic nuclei (arrows, **A**) that were increased in number relative to controls (**B**). (**C--D**) Cellular segregation was visualized using antibodies that demark the upper (rods, rhodopsin, blue) and lower (bipolar cells, Chx10, magenta) OPL boundaries. Lkb1-Ret animals displayed defects in neuron segregation with some rod nuclei remaining below the nascent OPL (**C**). The total area of the OPL (**D**) was also decreased in Lkb1-Ret animals relative to littermate controls. N = 4 control and N = 4 Lkb1-Ret animals. Scale bar = 25 µm. Data are represented as the mean ± the s.e.m. \*p\<0.05, non-parametric Mann-Whitney Rank Sum U-test.](elife-56931-fig2){#fig2}

We next asked whether LKB1 mediated outer retina synapse emergence involves similar pathways to those in synapse decline. We previously showed in old age that AMPK acts downstream of LKB1 to regulate rod synapse maintenance ([@bib46]). To test the role of AMPK in development, we generated animals in which both alpha subunits of *Ampk* (*Prkaa1 and Prkaa2*) were specifically deleted in retina (*Prkaa1^F/F^Prkaa2^F/F^; Vsx2-Cre*, [@bib38], hereafter referred to as Ampk-Ret). AMPK was dispensable for outer retina synapse emergence: Ampk-Ret mice showed no observable defects in OPL emergence or organization at P5, and the OPL was present at the proper location and time ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). In addition, outer retina neurons were morphologically normal at this time point ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Thus, the downstream drivers of outer retina synapse emergence differ from those involved in synapse maintenance and aging.

LKB1 regulates horizontal cell neurite refinement {#s2-2}
-------------------------------------------------

Horizontal cells and cones are the first to arrive and form contacts in the nascent OPL in a process that involves extensive neurite remodeling ([@bib48]; [@bib24]; [@bib5]). We thus examined the morphology of these neurons ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). In control animals, horizontal cells first emerge as radial neurons ([@bib49]), exhibiting long apical and basal neurites ([Figure 3A](#fig3){ref-type="fig"}). Between P3 and P5, horizontal cells then undergo a process of neurite refinement in which apically and basally targeted neurites become lateralized through largely unknown mechanisms to form a horizontal neural structure ([@bib42]). At P3, Lkb1-Ret horizontal cells were structurally indistinguishable from control animals (p*≥*0.12, [Figure 3A--B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A--B](#fig3s1){ref-type="fig"}). However, by P5 Lkb1-Ret horizontal cells displayed marked defects, extending numerous, long branches into the outer and inner retina ([Figure 3C](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1C--D](#fig3s1){ref-type="fig"}). This resulted in horizontal cell processes spanning a significantly increased retina area relative to controls (p\<0.05, [Figure 3D](#fig3){ref-type="fig"}). Horizontal cell neurites became largely lateralized in Lkb1-Ret animals by P8, although occasional, long apical horizontal neurites persisted at this timepoint ([Figure 3E--F](#fig3){ref-type="fig"}).

![Horizontal cell neurite restriction is altered with loss of LKB1.\
Horizontal cells and their neurites were identified in Lkb1-Ret and littermate controls during postnatal development using an antibody to calbindin (cyan). (**A--B**) Representative and reconstructed images (**A**) and quantification (**B**) of horizontal cell morphology at P3. Horizontal cells in both Lkb1-Ret and control animals exhibit stellate morphologies, and no significant structural differences were observed. N = 3 littermate controls and N = 7 Lkb1-Ret animals. (**C--D**) Representative and reconstructed images (**C**) and quantification (**D**) of horizontal cell morphology at P5. Lkb1-Ret horizontal cells fail to restrict their arbors at P5 (arrows) and instead display a marked radial morphology that results in horizontal processes spanning a significantly increased retinal area. N = 4 control and N = 8 Lkb1-Ret animals. (**E--F**) Representative and reconstructed images (**E**) and quantification (**F**) of horizontal cell morphology at P8. Horizontal cells in Lkb1-Ret animals refined their arbors, though occasional extensions into the outer retina were observed (arrow). N = 4 control and N = 4 Lkb1-Ret animals. Scale bars = 25 µm. Data are represented as the mean fluorescence relative to the distance from the apical surface. \*p\<0.05, unpaired two-tailed Student's *t* test.](elife-56931-fig3){#fig3}

We next investigated whether the defects in horizontal cell refinement represented a cell-intrinsic role for LKB1 in shaping horizontal cell architecture. To examine this, we selectively deleted *Stk11* from horizontal cells early in development (P2, [@bib5]) using a transgenic line that expresses *Cre* only in these neurons (*Gja10-ires-iCre,* previously called *Cx57-ires-iCre,* [@bib21]) to generate *Stk11^F/F^;Gja10-ires-iCre *animals. This line is hereafter referred to as Lkb1-HC. In situ for *Stk11* in Lkb1-HC retina confirmed cell-specific deletion of this transcript in horizontal cells ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Lkb1-HC mice showed no observable defects in OPL emergence or organization at P5, and the OPL was present at the proper location and time ([Figure 4A--C](#fig4){ref-type="fig"}). In addition, horizontal cells were morphologically normal at this time point ([Figure 4D](#fig4){ref-type="fig"}), and horizontal cells properly refined their neurites to the OPL ([Figure 4E](#fig4){ref-type="fig"}). These data indicate that LKB1 is dispensable in horizontal cells for the refinement of their arbors and for OPL emergence.

![LKB1 is not required in horizontal cells to restrict their neurites.\
Outer retina emergence and horizontal cell restriction were visualized in Lkb1-HC and littermate controls during postnatal development at P5. (**A--C**) Representative images (**A**) and quantification (**B**) of OPL emergence (DAPI, grey) and (**C**) distance of OPL patches from the apical surface at P5 in Lkb1-HC and littermate controls. The OPL emerges in Lkb1-HC animals at the proper time and location (**B**) and is located the same distance from the apical surface as controls (**C**, n = 239 control cells and n = 235 Lkb1-HC cells). N = 4 littermate controls and N = 3 Lkb1-HC animals. (**D--E**) Representative images (**D**) and quantification (**E**) of horizontal cell (calbindin, cyan) morphology at P5. Lkb1-HC horizontal cells restrict their arbors, spanning the same area as control mice. N = 4 control and N = 3 Lkb1-HC animals. Scale bars = 25 µm. Data are represented as the mean ± the s.e.m. (**B**, p\>0.05, non-parametric Mann-Whitney Rank Sum U-test), as a distribution of the distance of patches from the apical surface (**C**, p\>0.05, unpaired two-tailed Student's *t* test), or as the mean fluorescence relative to the distance from the apical surface (**E**, p\>0.05, unpaired two-tailed Student's *t* test).](elife-56931-fig4){#fig4}

Cone axon extension and maturation are disrupted in LKB1 mutant mice {#s2-3}
--------------------------------------------------------------------

What might be responsible for the defects in horizontal cell refinement? Given the high levels of LKB1 in outer retina neurons at P5, we questioned whether horizontal cell presynaptic partners might play a role in the horizontal cell defects we observed. In wild type animals, horizontal cells exclusively form contacts with developing presynaptic cone axons from P3-P5 as horizontal cells lateralize, while rod contacts occur later (\>P8, [@bib6]). We thus focused our attention on cones. To examine these cells, we used cone-specific antibodies to resolve the positioning of cone axons ([Table 1](#table1){ref-type="table"}). In control mice, cone axon extension was present at P1, and by P3, cones had reached 70.4% of their terminal axon length ([Figure 5A](#fig5){ref-type="fig"}). Axon extension was complete by P8 when cones reached their terminal axon length (34.7 ± 0.6 µm). Lkb1-Ret cones showed marked defects in cone axon extension. Mutant cones failed to properly develop axons at P1. Instead, axon extension was reduced, resulting in a decrease in average terminal axon length throughout the first postnatal week (68.3%, 57.7%, and 56.0% reduction in axon length relative to controls at P1, P3, and P5, p≤0.02, [Figure 5A--E](#fig5){ref-type="fig"}). Moreover, a large number of Lkb1-Ret cones lacked axons at early time points ([Figure 5C--E,G](#fig5){ref-type="fig"}). By P8, the majority of Lkb1-Ret cones had extended axons ([Figure 5F,G](#fig5){ref-type="fig"}), but they remained shorter than control cones (83.5% of the length of controls), and a small fraction still failed to reach the OPL (3.5%, p=0.0286, [Figure 5H](#fig5){ref-type="fig"}). Together, these data indicate that LKB1 is coordinately required for cone axon extension and restriction of horizontal cell process to enable OPL emergence.

![Cone axon extension requires LKB1.\
Cones and their axons were identified in Lkb1-Ret animals and littermate controls during postnatal development using an antibody to OPN1SW (green). (**A--B**) Representative images (**A**) and reconstructed cones (**B**) over development. (**C--F**) The distribution of the length of cone axons in control and Lkb1-Ret animals was quantified at P1 (**C**, n = 376 control cells and n = 515 Lkb1-Ret cells), P3 (**D**, n = 488 control cells and n = 478 Lkb1-Ret cells), and P5 (**E**, n = 572 control cells and n = 505 Lkb1-Ret cells). At each time point, Lkb1-Ret cones were shorter, and many also lacked axons. By P8, the distribution of length of cone axons in control and Lkb1-Ret animals was normal (**F**, n = 560 control cells and n = 552 Lkb1-Ret cells). (**G**) Quantification of cone axons over development. Lkb1-Ret animals displayed defects in cone axon extension beginning at P1 that persisted at P3 and P5, resulting in a significant decrease in axon length (N ≥ 4 control and N ≥ 5 Lkb1-Ret animals). (**H**) OPL localization of cone terminals was quantified at P8. There was a significant increase in the number of cones that failed to reach the OPL (N = 4 control and N = 4 Lkb1-Ret). Scale bars = 25 µm (**A**) and 5 µm (**B**). Data are represented as the mean ± the s.e.m. (**G--H**) or as the distribution of the length of cone axons (**C--F**). \*\*\*p\<0.001, \*\*p\<0.01, \*p\<0.05, non-parametric Mann-Whitney Rank Sum U-test.](elife-56931-fig5){#fig5}

###### Antibodies used in LKB1 mutant tissue analysis.

Antibodies were utilized that label individual neuron populations and synapses in the outer retina.

  Antibody name                   Immunogen                                                                                                        Labeling specificity                                       Source                                                                                                       Concentration
  ------------------------------- ---------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ ---------------
  Calbindin D-28k                 Full-length recombinant human Calbindin D-28K                                                                    Horizontal cells; amacrine cells; retinal ganglion cells   Novus biologicals; chicken polyclonal; NBP2-50028; no RRID                                                   1:2000
  Calbindin D-28k                 Recombinant ratcalbindin D-28k (CB)                                                                              Horizontal cells; amacrine cells; retinal ganglion cells   Swant; rabbit polyclonal; CB38; RRID:[AB_10000340](https://scicrunch.org/resolver/AB_10000340)               1:10,000
  Chx10                           Recombinant protein derived from the N terminal of the human Chx10 protein conjugated to KLH (aa 1--131)         Bipolar cells                                              Exalpha; sheep polyclonal; X1180P; RRID:[AB_2314191](https://scicrunch.org/resolver/AB_2314191)              1:300
  OPN1SW                          Peptide mapping at the N-terminus of the opsin protein encoded by OPN1SW of human origin                         Cone photoreceptors                                        Santa Cruz; goat polyclonal; sc-14363; RRID:[AB_2158332](https://scicrunch.org/resolver/AB_2158332)          1:500
  Piccolo                         Recombinant protein corresponding to AA 4439 to 4776 from rat Piccolo                                            Ribbon synapses                                            Synaptic Systems; rabbit polyclonal; 142 003; RRID:[AB_2160182](https://scicrunch.org/resolver/AB_2160182)   1:500
  Protein Kinase C alpha (PKCa)   Purified bovine brain protein kinase C                                                                           Rod bipolar cells                                          Abcam; mouse monoclonal; ab31; RRID:[AB_303507](https://scicrunch.org/resolver/AB_303507)                    1:500
  PSD95                           Synthetic peptide corresponding to Mouse PSD95 aa1--100 (C-terminal) conjugated to keyhole limpet haemocyanin.   Photoreceptor terminals                                    Abcam; goat polyclonal; ab12093; RRID:[AB_298846](https://scicrunch.org/resolver/AB_298846)                  1:500
  Rhodopsin                       Recombinant fragment corresponding to Bovine Rhodopsin (N terminal)                                              Rod photoreceptors                                         Abcam; mouse monoclonal; ab98887; RRID:[AB_10696805](https://scicrunch.org/resolver/AB_10696805)             1:500
  RIBEYE                          Recombinant protein corresponding to AA95 to 207 from rat Ribeye                                                 Ribbon synapses                                            Synaptic Systems; rabbit polyclonal; 192 103; RRID:[AB_2086775](https://scicrunch.org/resolver/AB_2086775)   1:500
  VGLUT1                          Recombinant protein corresponding to AA456 to 560 from rat VGLUT1                                                Photoreceptor terminals                                    Synaptic Systems; rabbit polyclonal; 135 302; RRID:[AB_887877](https://scicrunch.org/resolver/AB_887877)     1:500

We then examined the contacts between horizontal cells and cones. We reasoned that if cone and horizontal cell interaction modulates synapse layer emergence, then: 1) normal cone axon extension should be accompanied by a coordinated reduction in horizontal cell neurite length, and 2) the axon extension deficits in LKB1 mutant cones should be followed by mislocalized contacts between horizontal cells and cones. To examine this, we co-labeled cones and horizontal cells and quantified the number of terminal contacts over time. We began our analysis in control animals at P3 when cone axons are 70.4% of their adult length and horizontal cells have yet to restrict their arbors to the OPL ([Figure 3A](#fig3){ref-type="fig"}; [Figure 5A](#fig5){ref-type="fig"}). Many horizontal cell processes were apposed to cone terminals at this time (77.8%), and terminal contacts occurred within 20.4 ± 1.4 µm of the horizontal cell soma ([Figure 6A--C](#fig6){ref-type="fig"}). In addition, horizontal cell contacts with cones outside of the axon terminal occurred with some frequency in controls, with 22.2% of contacts occurring at non-terminal positions. By P5, however, the fidelity and restriction of these appositions to the axon terminal increased to nearly 96.8% in controls. Their location reflected horizontal neurite restriction, with an average contact distance within 2.6 ± 0.1 µm of the horizontal cell soma ([Figure 6D--F](#fig6){ref-type="fig"}). At this time point and beyond, horizontal cell contacts on control cones rarely occurred outside of the axon terminal (3.2% at P5 and 4.1% at P8, [Figure 6E,H](#fig6){ref-type="fig"}).

![Horizontal cells in LKB1 mutants contact cones at terminal and non-terminal positions.\
Horizontal cell and cone contacts (calbindin, red; OPN1SW, green) were identified in Lkb1-Ret and littermate controls during postnatal development. (**A**) Representative images of horizontal cell-cone contacts at P3. Higher magnification images are displayed of the contacts (stars demarcate terminal contacts; arrows demarcate non-terminal contacts). Scale bars = 25 µm. (**B--C**) The location of contacts between cones and horizontal cells was quantified at P3. Lkb1-Ret animals showed a small but significant reduction in terminal contacts and an increase in non-terminal contacts relative to controls (**B**). The length of horizontal cell neurites that formed contacts with cones in control and Lkb1-Ret animals were measured and binned. The mean distance of the terminal contacts relative to the location of horizontal cell somas did not significantly differ between groups (**C**, n = 135 control cells and n = 159 Lkb1-Ret). N = 3 control and N = 5 Lkb1-Ret animals. (**D**) Representative images of horizontal cell-cone contacts at P5. Higher magnification images are displayed of the contacts (stars demarcate terminal contacts; arrows demarcate non-terminal contacts). (**E--F**) The location of contacts between cones and horizontal cells was quantified at P5. Lkb1-Ret animals showed a significant reduction in terminal contacts and an increase in non-terminal contacts relative to controls (**E**). The length of horizontal cell neurites that formed contacts with cones in control and Lkb1-Ret animals were measured and binned. The mean distance of the terminal contacts relative to the location of horizontal cell somas significantly increased in Lkb1-Ret animals (**F**). N = 4 control and N = 5 Lkb1-Ret animals. (**G**) Representative images of horizontal cell-cone contacts at P8. Higher magnification images are displayed of the contacts (stars demarcate terminal contacts; arrows demarcate non terminal contacts). (**H--I**) The location of contacts between cones and horizontal cells was quantified at P8. Lkb1-Ret animals showed a small but significant reduction in terminal contacts and an increase in non-terminal contacts relative to controls (**H**). The length of horizontal cell neurites that formed contacts with cones in control and Lkb1-Ret animals were measured and binned. The mean distance of the terminal contacts relative to the location of horizontal cell somas significantly increased in Lkb1-Ret animals (**I**). N = 4 control and N = 4 Lkb1-Ret animals. Scale bars = 25 µm. Data are represented as the mean ± the s.e.m. (**B**, **E**, **H**, \*\*\*p\<0.001, \*\*p\<0.01, \*p\<0.05, unpaired t-test across rows corrected for multiple comparisons using the Holm-Sidak method) or as the distribution of length of horizontal cell neurites that form contacts with cones (**C**, **F**, **I**, \*p\<0.05, non-parametric Mann-Whitney Rank Sum U-test).](elife-56931-fig6){#fig6}

In Lkb1-Ret mice we observed three notable differences in this pattern. First, the relative frequency of horizontal cell contacts with cones differed, with more occurring at non-terminal positions. Second, the presence of these alterations corresponded with the onset of horizontal cell restriction defects. Third, the location of pre and postsynaptic contacts was corrected in concert with cone axon extension. In particular, at P3 when control and Lkb1-Ret horizontal cells are morphologically similar ([Figure 3A](#fig3){ref-type="fig"}), 66.2% of horizontal cell processes were apposed to cone terminals at this time, and these occurred within 22.0 ± 0.6 µm of horizontal cell soma. However, an increase in the number of non-axon contacts was observed in LKB1 mutants relative to controls (34.3% increase, [Figure 6A--C](#fig6){ref-type="fig"}). Furthermore, at P5, the location of Lkb1-Ret horizontal cell contacts differed significantly: the majority were 16.7 ± 0.8 µm away from the horizontal cell soma (an 84.4% increase in distance), consistent with the defects in cone axon extension and horizontal cell neurite refinement at this time (84.5% increase in horizontal cell neurite length, p=0.0159, [Figure 6D--F](#fig6){ref-type="fig"}). In addition, horizontal cells made more contacts with cones beyond the axon terminal (82.1% increase in non-terminal contacts), with many occurring at the soma and the cone inner and outer segment ([Figure 6E](#fig6){ref-type="fig"}). These contact location errors were largely corrected by P8, as Lkb1-Ret cone axons grew ([Figure 6G--I](#fig6){ref-type="fig"}). Together, these data suggest cone terminal localization, horizontal neurite restriction, and contact location may be coordinately regulated.

LKB1 is required for synapse-associated protein localization in cones {#s2-4}
---------------------------------------------------------------------

A key feature of laminated circuits is that synapse formation occurs at a restricted cellular location. This restriction is vital for circuit organization and thus function. What determines the location of these contacts? While several factors are likely to play roles, synapse-associated proteins have been shown to be required for OPL organization ([@bib35]; [@bib32]). Thus, we wondered how OPL emergence might impact the presence and localization of synapse-associated molecules. To assess this, we defined the timing, levels, and location of four cone terminal proteins to identify those present at the early stages of OPL formation ([Table 1](#table1){ref-type="table"}). In control animals, the synapse-associated proteins RIBEYE, piccolo, and PSD95 were absent prior to synapse formation but present and restricted to the OPL at P5, when synapses emerge ([Figure 7A](#fig7){ref-type="fig"}). The levels and localization of these proteins increased at P8 as the OPL matured ([Figure 7B](#fig7){ref-type="fig"}). This pattern of synapse protein location differed in LKB1 mutants. Consistent with the absence of the OPL at P5, the levels of synapse-associated proteins were reduced in LKB1 mutants at P5 ([Figure 7A--C](#fig7){ref-type="fig"}). As the OPL emerged in LKB1 mutants at P8, synapse proteins became present, though their levels were lower than those in control animals ([Figure 7B--C](#fig7){ref-type="fig"}).

![Synaptic protein distribution across development.\
Outer retina synapse-associated proteins were stained and quantified over development to assess levels and localization. (**A--C**) Representative images (**A**) and quantification (**B--C**) of VGLUT1, RIBEYE, PSD95, and Piccolo at P1, P3, P5, and P8 in control and Lkb1-Ret animals. Data in (**B**) and (**C**) are presented as a heatmap indicating the corrected total cell fluorescence of each retinal layer occupied by the synapse protein signal using a gradient scale where white to blue depicts low to high levels of fluorescent intensity (0--3000, respectively). Scale bars = 25 µm.](elife-56931-fig7){#fig7}

To examine LKB1-driven synapse protein disorganization in more detail, we obtained high-resolution views of RIBEYE localization in control and Lkb1-Ret cones at P5 using expansion microscopy ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}; [@bib15]). In control animals, all cone terminals displayed one or more RIBEYE puncta ([Figure 8A--B](#fig8){ref-type="fig"}), consistent with the numerous ribbon synapses formed by cone pedicles ([@bib36]). Further, RIBEYE was largely restricted to the cone terminal. We noted two differences in RIBEYE localization in LKB1 mutant cones. First, RIBEYE was absent from cone terminals in some cases ([Figure 8B](#fig8){ref-type="fig"}, star). Second, RIBEYE was present at higher levels in mutant cone somas ([Figure 8A--B](#fig8){ref-type="fig"}, arrowhead). These data suggest outer retina synapse emergence defects are accompanied by alterations to the localization of synapse-associated proteins.

![Expansion microscopy shows altered RIBEYE localization in LKB1 mutant cones.\
(**A**) Representative reconstructions of cones from Lkb1-Ret animals and control littermates at P5 are shown following staining with RIBEYE (red) and OPN1SW (green). Samples were expanded, imaged, and reconstructed. (**B**) Reconstructed control and Lkb1-Ret cone terminals show RIBEYE localization defects in Lkb1-Ret animals. Unlike controls, RIBEYE is present in the cell soma (arrowhead) and can be absent from the cone terminal (star). Scale bars = 5 µm.](elife-56931-fig8){#fig8}

LKB1 is required for early localization of VGLUT1 {#s2-5}
-------------------------------------------------

We next considered the timing of synapse layer emergence relative to the presence of synapse-associated proteins. Interestingly, VGLUT1 was present in cones earlier than other synapse-associated proteins: it could be visualized as early as P1 in controls, preceding other synapse-associated proteins by at least 48 hr ([Figure 7](#fig7){ref-type="fig"}). In control animals at P1, VGLUT1 was predominantly found in cones in the latter third of the maturing axon and at the axon terminal ([Figure 9A](#fig9){ref-type="fig"}). By P5, VGLUT1 was largely restricted to cone axon terminals (99%, [Figure 9B](#fig9){ref-type="fig"}), and VGLUT1 staining became more pronounced from P5 to P8 where it overlapped with cone pedicles as they grew ([Figure 9C](#fig9){ref-type="fig"}).

![LKB1 regulates VGLUT1 levels and localization.\
Cones were co-labeled with OPN1SW (green) and vesicular glutamate transporter 1 (VGLUT1, magenta) in Lkb1-Ret animals and control littermates. (**A--C**) At P1 (**A**), P5 (**B**), and P8 (**C**) Lkb1-Ret animals have a decreased number of cone terminals that are VGLUT1 positive and show displaced VGLUT1 localization relative to controls. (**D**) The number of cones that are VGLUT1 positive is significantly reduced in Lkb1-Ret animals relative to control littermates at all time points. (**E**) Representative images of VGLUT1 localization in single cones. In control animals, VGLUT1 is found primarily in the terminal (left panel), while Lkb1-Ret animals show cones with abnormal VGLUT1 localization within the cell soma and terminal or within the soma only (right panel). Scale bars = 5 µm. (**F--H**) Quantification of the number of cones that contain VGLUT1 only within the cone terminal (**F**), in the terminal and the soma (**G**), or only within the soma (**H**) at P1, P5, and P8. N ≥ 3 control and N ≥ 4 Lkb1-Ret animals. Scale bars = 25 µm. Data are represented as the mean ± the s.e.m. \*\*\*p\<0.001, \*\*p\<0.01, \*p\<0.05, unpaired t-test across rows corrected for multiple comparisons using the Holm-Sidak method.](elife-56931-fig9){#fig9}

We then asked whether the pattern of synapse-associated protein differed from that in Lkb1-Ret mice. First, fewer Lkb1-Ret cones contained VGLUT1 over time (31.3%, 12.7%, 12.7%, and 3.8% reduction at P1, P3, P5, and P8 respectively, p≤0.01, [Figure 9D](#fig9){ref-type="fig"}). Second, Lkb1-Ret cones that contained VGLUT1 showed abnormal protein localization. Unlike control animals, VGLUT1 could be found in the soma in addition to the axon ([Figure 9A--C,E](#fig9){ref-type="fig"}). Indeed, in some cases VGLUT1 was present only in the soma of Lkb1-Ret cones at P5 (15.7% of Lkb1-Ret cones and 0.1% control cones, p\<0.0001) even when an axon was present (5.4% of Lkb1-Ret cones and 0.8% control cones, p\<0.0001, [Figure 9F--H](#fig9){ref-type="fig"}). Together, these changes resulted in a 95.2% increase in VGLUT1 mislocalization to the soma of Lkb1-Ret animals relative to controls (p\<0.0001, [Figure 9D--F](#fig9){ref-type="fig"}). Notably abnormal VGLUT1 labeling persisted in Lkb1-Ret animals through P8 even when axon extension defects were largely corrected (p=0.0006, [Figure 6G](#fig6){ref-type="fig"}, [Figure 9C,F--H](#fig9){ref-type="fig"}).

To obtain high-resolution views of VGLUT1 localization in control and Lkb1-Ret cones, we again performed expansion microscopy ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}; [@bib15]). We reconstructed VGLUT1 localization within cones in detail and found marked quantitative differences in fluorescent intensity across different neuronal compartments ([Figure 10A](#fig10){ref-type="fig"}). Relative to controls, VGLUT1 levels were 76.4% and 82.6% decreased in the axon and axon terminal of Lkb1-Ret animals, respectively (p\<0.04, [Figure 10B](#fig10){ref-type="fig"}). In contrast, VGLUT1 levels in the soma of Lkb1-Ret mice exhibited a 62.5% increase in fluorescence (p\<0.04, [Figure 10B](#fig10){ref-type="fig"}). In addition, we noted morphological defects in Lkb1-Ret cones in which VGLUT1 was highly localized to the soma. In these instances, cone soma had a distal bulge in which VGLUT1 was concentrated ([Figure 10C](#fig10){ref-type="fig"}, associated [Figure 10---videos 1](#fig10video1){ref-type="video"} and [2](#fig10video2){ref-type="video"}). Together, these data suggest that LKB1-induced defects in axon extension impact the localization and distribution of VGLUT1 and other synapse-associated proteins, with decreased localization to the axon and axon terminal and increased localization to the soma.

![VGLUT1 is mislocalized in LKB1 mutant cone somas.\
(**A**) Representative reconstructions of cones from Lkb1-Ret animals and control littermates at P5 are shown following staining with VGLUT1 (magenta) and OPN1SW (green). Samples were expanded, imaged, and reconstructed. (**B**) Quantification of VGLUT1 expression in the soma, axon, and axon terminal of cones in both control and Lkb1-Ret animals. Data are presented as a line graph indicating the corrected total cell fluorescence within each neuron compartment occupied by VGLUT1 signal. (**C**) Reconstructed control and Lkb1-Ret cone somas show morphological defects in Lkb1-Ret animals. VGLUT1 is highly localized to a bulge associated with the cell soma (arrowhead). Scale bars = 5 µm. Data are represented as the mean ± the s.e.m.](elife-56931-fig10){#fig10}

Based on the synapse protein defects we observed in Lkb1-Ret animals, we questioned whether these ectopic protein patches may correspond with the location of mislocalized neural contacts. To examine this, we used VGLUT1 staining as a readout for synapse protein mislocalization since it was the only protein we identified that was present at high levels during OPL emergence (P3-P5). We first asked whether horizontal cell neurites in Lkb1-Ret animals targeted VGLUT1 presynaptic regions. Horizontal cells and VGLUT1 were co-labeled in control and Lkb1-Ret animals at P5, and the cellular position of VGLUT1 in cones and its apposition to horizontal cell neurites were determined. In control and in Lkb1-Ret mice, the majority of horizontal cell neurites colocalized with VGLUT1 patches (98.5% and 92.7%, respectively; [Figure 11A--B](#fig11){ref-type="fig"}). Similarly, the majority of VGLUT1 positive regions were contacted by horizontal cell processes (98.5% and 92.9% in control and Lkb1-Ret mice, respectively; [Figure 11C](#fig11){ref-type="fig"}). We then asked whether the relative location of VGLUT1 patches impacted the fidelity of horizontal cell neurite contacts. Cones, horizontal cells and VGLUT1 were co-labeled in control and Lkb1-Ret animals at P5, and the cellular position of VGLUT1 in cones and its apposition to horizontal cell neurites were determined. In control mice, contacts were largely localized to the terminal (98.4%; [Figure 11A,D](#fig11){ref-type="fig"}). However, in Lkb1-Ret animals horizontal cell neurites targeted ectopic VGLUT1 presynaptic patches distributed along the cone soma and proximal axon (9.9 fold change in non-terminal contacts; p\<0.001; [Figure 11A,D](#fig11){ref-type="fig"}). These data suggest that synapse-associated protein localization in cones may participate in the restriction of neurite interaction to the cone terminal.

![Horizontal cell neurites contact ectopic VGLUT1 locations.\
(**A**) Representative images of horizontal cells (calbindin, cyan) and VGLUT1 (magenta) contacts at P5 in Lkb1-Ret mice and littermate controls are shown. The boxed area is presented as a higher magnification image highlighting horizontal cells contacting VGLUT1 at cone terminals (star) and at non-terminal cone positions (arrow). (**B--C**) The percent of horizontal cell processes contacting VGLUT1 (**B**) and the percent of VGLUT1 regions that were contacted by horizontal cells (**C**) were quantified at P5. Nearly all horizontal cell processes contacted VGLUT1 and nearly all VGLUT1 positive regions were contacted by horizontal cell processes. The relative percent of contacts did not significantly differ between control and Lkb1-Ret animals. N = 4 control and N = 3 Lkb1-Ret animals. (**D**) The relative location of horizontal cell processes contacting VGLUT1 at cone terminals and non-terminal cone positions were quantified at P5. There is a significant increase in horizontal cell processes contacting non-terminal VGLUT1 in cones in Lkb1-Ret animals compared to control. N = 4 control and N = 3 Lkb1-Ret animals. Scale bars = 25 µm (upper panel) and 5 µm (lower panel). Data are represented as the mean ± the s.e.m. (**B,C,** non-parametric Mann-Whitney Rank Sum U-test; **D,** \*\*\*p\<0.001, unpaired t-test across rows corrected for multiple comparisons using the Holm-Sidak method).](elife-56931-fig11){#fig11}

Discussion {#s3}
==========

The events that accompany synapse formation often overlap in space and time, so it has been difficult to resolve which processes drive the formation of specific patterns of connectivity. Here, we examined the role of LKB1 in synapse layer emergence by utilizing the outer retina where synapses occur at one distinct cellular location. The OPL appears early in development as an ordered cell-free layer that is comprised of contacts between cones and horizontal cells. We show that LKB1 is a key driver of synapse layer emergence independent of AMPK, which is required for adult synapse maintenance. LKB1 deletion results in OPL disorganization and the appearance of small patches interspersed by nuclei that disrupt the synapse lamina. These alterations coincided with specific defects in horizontal cell neurite restriction, which were accompanied by defective axon extension in presynaptic cones. Furthermore, there was a failure of synapse-associated proteins to localize to the axon terminal, and horizontal cell neurites were misdirected to these ectopic synapse protein regions. Together, these data suggest an LKB1-dependent pathway that instructs the timing and location of connectivity in the outer retina via regulation of neuron structure and synapse-associated protein localization.

LKB1 coordinates neurite remodeling to drive outer retina synapse layer emergence {#s3-1}
---------------------------------------------------------------------------------

The morphological steps that characterize OPL development have been well documented ([@bib48]), allowing us to focus our attention on neurons that are first to form nascent synaptic contacts in this region, cones and horizontal cells. Both are born prenatally ([@bib13]) and then extend neurites that terminate in the future OPL. Our data are consistent with a model in which cones and horizontal cell remodeling regulate the first stages of OPL emergence. We provide several lines of evidence in support of this idea. First, cone axon extension coincides precisely with horizontal cell restriction, and this arrangement is perturbed in LKB1 mutants when axons fail to extend. Second, when horizontal cells eventually refine and cone axons extended in LKB1 mutants, OPL defects were corrected in concert. Other studies also support this model. Zebrafish mutants lacking the synapse protein synaptojanin one show delayed OPL emergence and decreased OPL area that coincided with cone morphological alterations ([@bib22]). Notably, these processes are likely distinct from OPL sublamination mechanisms, as this occurs later in development and is regulated by Wnt signaling pathways ([@bib48]). Together, these results suggest that LKB1-driven neurite maturation is important for the precise timing and organization of OPL emergence while other cell types or processes regulate later stages of OPL maturation.

How might cones and horizontal cells interact to regulate synapse layer formation? Horizontal cells undergo marked refinement in coordination with OPL emergence and reorient their organizational axis from a basal/apical orientation to a horizontal one. Several genes have been implicated in horizontal cell birth (*Prox1* and *Foxn4*, [@bib18]; [@bib31]), migration (*Lhx1*, [@bib41]) and neurite confinement in late development and adulthood (*Sema6a* and *PlexinA4*, [@bib35], *Cacna1*, [@bib17], and *Bassoon*, [@bib7]). However, the mechanisms that are responsible for horizontal cell reorientation and refinement are unknown. Our data suggest a model in which LKB1-driven cone axon extension and horizontal cell arbor refinement are coordinately regulated. In support of this idea, mislaminated horizontal cell processes maintained contact with mistargeted cone axons in LKB1 mutants, and horizontal cell lamination defects were corrected in precise coordination with cone axon extension. Further, deletion of LKB1 in the retina generally, but not in horizontal cells specifically, led to horizontal cell refinement defects. Together, these data suggest that refinement of neurites from a basal/apical orientation to a horizontal orientation early in development may depend on LKB1-mediated contact with developing cone axons.

Defective synapse-associated protein localization in LKB1 mutant mice {#s3-2}
---------------------------------------------------------------------

How might presynaptic neurite growth regulate synapse layer formation in the outer retina? Our studies suggest terminal maturation and synapse-associated protein levels or localization may participate. In particular, VGLUT1 showed early and persistent localization defects. VGLUT1 is a vesicular glutamate transporter, and cones rely on the vesicular release of glutamate for synaptic neurotransmission after axon development is complete ([@bib53]; [@bib20]; [@bib1]). Consistent with this, VGLUT1 is required for proper glutamate transmission and photoreceptor activity ([@bib27]; [@bib54]). VGLUT1 levels have also been tied to synapse emergence in the cortex downstream of MECP2 ([@bib14]). Other studies have also found links between synapse protein localization, axon extension, and synapse formation. For example, neurotransmitter vesicle fusion and release have been shown to be important for axon outgrowth ([@bib19]). Interestingly, the neuromuscular junction requires L-type calcium channels to regulate synapse formation. Loss of these calcium channels results in loss of acetylcholine receptor patterning, as well as excessive nerve branching and failure of axons to recognize postsynaptic targets ([@bib28]; [@bib29]). It is also possible that LKB1 may directly regulate synapse protein localization independent of cone axon extension, as VGLUT1 and RIBEYE were mislocalized in cones even when axons were present. Consistent with this idea, LKB1 has been shown to be involved in the polarized transport of proteins in *Drosophila* epithelial cells ([@bib26]) and mouse hepatocytes ([@bib23]). Together, these data suggest that axon extension, terminal maturation, and polarized synapse protein transport might be molecularly coordinated and implicate LKB1 as a regulator of these events.

Diverse roles for LKB1 {#s3-3}
----------------------

LKB1 is a serine/threonine kinase that is best known for its tumor suppressor functions ([@bib50]), but it is increasingly recognized as a key regulator of the nervous system ([@bib30]). Though it is expressed broadly throughout the CNS, its function appears remarkably dependent upon both neuron type and maturation stage. Perhaps its best studied role is in axon development, but even here, mechanisms differ. In hippocampal and cortical neurons LKB1 deletion impairs axon initiation ([@bib4]; [@bib52]) and branching ([@bib16]). In contrast, LKB1 is dispensable for axon formation in the brainstem and spinal cord, which depend instead on SAD kinases ([@bib33]). In developing outer retina, LKB1 had no detectable effect on outer retina neuron cell numbers but was required for cone axon initiation and elongation as well as OPL emergence. Notably, both in retina and in brain, LKB1-deficient neurons do eventually grow axons that approximate the lengths reached in controls, suggesting that LKB1-independent pathways participate in axon growth in diverse neuron types. Thus, LKB1 is required at different stages of axon development that may point to distinct LKB1-dependent and independent mechanisms by which neuron subtypes generate and maintain polarity.

Our results suggest at least two additional functions for LKB1 in neurons: synapse layer formation and synapse protein localization. What mechanisms might be at play? Unlike rod aging, which requires AMPK downstream of LKB1 ([@bib46]), cone-axon extension appears independent of AMPK signaling. LKB1 may instead impact developmental processes through regulation of microtubule formation or motor protein movement via its role in MARK activation ([@bib39]; [@bib10]). Alternatively, LKB1 also regulates energy production in response to mechanical force ([@bib8]), which may be important for physically anchoring pre and postsynaptic terminals together. In future studies it will be interesting to determine the distinct, neuron-specific downstream pathways that LKB1 engages.

In summary, we have uncovered a key molecular regulator responsible for the emergence of ordered connectivity in the outer retina. We have also shown how the localization of pre and postsynaptic arbors can sculpt the emergence of synapse lamina and shed light on the role of neurite remodeling and synapse-associated protein localization in these events. Particularly fascinating is the apparent cellular specificity with which LKB1 functions despite its ubiquitous expression ([@bib46]). This suggests additional levels of regulation that could be inherent to the diversity in neuron developmental processes, the localization of LKB1 itself, or the presence or absence of downstream signaling molecules.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                                 Designation                                              Source or reference                                                                                 Identifiers                                                                               Additional\
  (species) or resource                                                                                                                                                                                                                                                                                                information
  ------------------------------------------------------------- -------------------------------------------------------- --------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ---------------
  Gene (*Mus musculus*)                                         *Stk11*                                                  Mouse Genome Informatics                                                                            MGI:1341870\                                                                              
                                                                                                                                                                                                                             NCBI Gene: 20869                                                                          

  Gene (*Mus musculus*)                                         *Prkaa1*                                                 Mouse Genome Informatics                                                                            MGI:2145955\                                                                              
                                                                                                                                                                                                                             NCBI Gene: 105787                                                                         

  Gene (*Mus musculus*)                                         *Prkaa2*                                                 Mouse Genome Informatics                                                                            MGI:1336173\                                                                              
                                                                                                                                                                                                                             NCBI Gene: 108079                                                                         

  Strain, strain background (*Mus musculus*, male and female)   *Stk11^F/F^ (*previously called *Lkb1^F/F^)*             [@bib3]; DOI:[10.1038/nature01045](https://doi.org/10.1038/nature01045)                                                                                                                       

  Strain, strain background (*Mus musculus*, male and female)   *Prkaa1 ^F/F^ Prkaa2 ^F/F^*                              [@bib38]; DOI:[10.1038/nature09571](https://doi.org/10.1038/nature09571)                                                                                                                      

  Strain, strain background (*Mus musculus*, male and female)   *Vsx2-Cre* (previously called*Chx10-Cre*)                The Jackson Laboratory                                                                              RRID:[IMSR_JAX:005105](https://scicrunch.org/resolver/IMSR_JAX:005105)                    

  Strain, strain background (*Mus musculus*, male and female)   *Gja10-ires-iCre* (previously called *Cx57-ires-iCre)*   [@bib21]; DOI:[10.1523/ENEURO.0148--15.2016](https://doi.org/10.1523/ENEURO.0148%E2%80%9315.2016)                                                                                             

  Antibody                                                      Chicken polyclonal anti-Calbindin                        Novus Biologicals                                                                                   NBP2-50028                                                                                IHC (1:2000)

  Antibody                                                      Rabbit polyclonal anti-Calbindin                         Swant                                                                                               CB38; RRID:[AB-100000340](https://scicrunch.org/resolver/AB-100000340)                    IHC (1:10000)

  Antibody                                                      Sheep polyclonal anti-Chx10                              Exalpha                                                                                             X1180P; RRID:[AB_2314191](https://scicrunch.org/resolver/AB_2314191)                      IHC (1:300)

  Antibody                                                      Goat polyclonal anti-OPN1SW                              Santa Crus                                                                                          Sc-14363; RRID:[AB_2158332](https://scicrunch.org/resolver/AB_2158332)                    IHC (1:500)

  Antibody                                                      Rabbit polyclonal anti-Piccolo                           Synaptic Systems                                                                                    142003; RRID:[AB_2160182](https://scicrunch.org/resolver/AB_2160182)                      IHC (1:500)

  Antibody                                                      Mouse monoclonal anti-Protein Kinase C α                 Abcam                                                                                               Ab31; RRID:[AB_303507](https://scicrunch.org/resolver/AB_303507)                          IHC (1:500)

  Antibody                                                      Goat polyclonal anti-PSD95                               Abcam                                                                                               Ab12093; RRID:[AB_298846](https://scicrunch.org/resolver/AB_298846)                       IHC (1:500)

  Antibody                                                      Mouse monoclonal anti-rhodopsin                          Abcam                                                                                               Ab98887; RRID:[AB_10696805](https://scicrunch.org/resolver/AB_10696805)                   IHC (1:500)

  Antibody                                                      Rabbit polyclonal anti-RIBEYE                            Synaptic Systems                                                                                    192103; RRID:[AB_2086775](https://scicrunch.org/resolver/AB_2086775)                      IHC (1:500)

  Antibody                                                      Rabbit polyclonal anti-VGLUT1                            Synaptic Systems                                                                                    135302; RRID:[AB_887877](https://scicrunch.org/resolver/AB_887877)                        IHC (1:500)

  Commercial assay or kit                                       RNeasy Mini Kit                                          Qiagen                                                                                              Cat. No. 74104                                                                            

  Commercial assay or kit                                       RNAscope Multiplex Fluorescent v2                        ACDbio                                                                                              Cat. No. 323120                                                                           

  Other                                                         RNAscope Probe-Mm-Stk11                                  ACDbio                                                                                              Cat. No. 469211                                                                           

  Chemical compound, drug                                       Acryloyl-X, SE                                           Thermofisher                                                                                        Cat. No. A20770                                                                           

  Chemical compound, drug                                       TEMED                                                    Thermofisher                                                                                        Cat. No. 17919                                                                            

  Chemical compound, drug                                       APS                                                      Sigma Aldrich                                                                                       Cat. No. 248614                                                                           

  Chemical compound, drug                                       4-Hydroxy-TEMPO                                          Sigma Aldrich                                                                                       Cat. No. 176141                                                                           

  Chemical compound, drug                                       Sodium Acrylate                                          Sigma Aldrich                                                                                       Cat. No. 408220                                                                           

  Chemical compound, drug                                       Acrylamide                                               Sigma Aldrich                                                                                       Cat. No. A9099                                                                            

  Chemical compound, drug                                       N-N'-Methylenebisacrylamide                              Sigma Aldrich                                                                                       Cat. No. M7279                                                                            

  Chemical compound, drug                                       Sodium Chloride                                          Sigma Aldrich                                                                                       Cat. No. S9888                                                                            

  Software, algorithm                                           ImageJ                                                   NIH                                                                                                 <https://imagej.nih.gov/ij/>;\                                                            
                                                                                                                                                                                                                             RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)                              

  Software, algorithm                                           Imaris 7                                                 Oxford Instruments                                                                                  RRID:[SCR_007370](https://scicrunch.org/resolver/SCR_007370)                              

  Software, algorithm                                           Prism7                                                   Graphpad                                                                                            <http://www.graphpad.com>; RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)   
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mouse strains {#s4-1}
-------------

Mouse strain names were modified as per eLife's gene nomenclature policy. The *Stk11* (*Lkb1*) conditional null mutant *Stk11^F/F^* has been described previously ([@bib3]) and was provided by R. DePinho, MD Anderson Cancer Center. In this strain, *loxP* sequences flank exons 2--6, resulting in a complete loss of LKB1 function. To broadly delete LKB1 in the retina, *Stk11^F/F^* mice were crossed to *Vsx2-Cre* ([@bib44]), provided by C. Cepko, Harvard University) to generate animals referred to here as Lkb1-Ret mice. To delete LKB1 in horizontal cells we crossed *Stk11^F/F^* animals to the *Gja10-ires-iCre* line ([@bib21]) to generate animals referred to here as Lkb1-HC mice. For these lines, *Stk11^F/F^* littermates were used as controls. To look at the role of AMPK, we used the conditional null mutant *Prkaa1^F/F^Prkaa2^F/F^* which has been previously described ([@bib38]) and was provided by Dr. Daisuke Nakada, Baylor College of Medicine. To broadly delete both alpha subunits of *Ampk* (*Prkaa1 and Prkaa2*) in the retina, *Prkaa1^F/F^Prkaa2^F/F^* mice were crossed to *Vsx2-Cre* to generate animals referred to here as Ampk-Ret. For these lines, *Prkaa1^F/F^Prkaa2^F/F^* littermates were used as controls. Experiments were carried out in male and female mice in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the NIH under protocols approved by the BCM Institutional Animal Care and Use Committee.

Immunohistochemistry {#s4-2}
--------------------

Eyes were collected from animals at P1, P3, P5, P8, and P14. The day of birth was designated as postnatal day 0 (P0). Whole eyes were fixed for 45 min in 4% paraformaldehyde and then rinsed with PBS. Retina cross sections were prepared as described ([@bib46]). Briefly, eye cups were dissected, and the cornea and lens were removed. The samples were then cryoprotected in 30% sucrose, embedded in Optimal Cutting Temperature (OCT) compound (Sakura, Torrance, CA), frozen in methyl butane on dry ice, sectioned at 20 μm, and then mounted on Superfrost Plus slides (VWR). Slides were incubated with blocking solution (3% normal donkey serum and 0.3% Triton X-100 in PBS) for 1 hr, and then with primary antibodies ([Table 1](#table1){ref-type="table"}) O/N at 4°C. Slides were washed with PBS three times for 10 min and incubated with secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 hr at room temperature. Slides were then washed with PBS three times for 10 min. All samples were mounted in Vectashield (Vector Laboratories, Burlingame, CA). The images were acquired on an Olympus Fluoview FV1200 confocal microscope and processed using Fiji. For cone and horizontal cell neuron reconstruction, 3D rendered images of cones were generated using Imaris.

Expansion microscopy {#s4-3}
--------------------

Expansion microscopy was performed as previously described ([@bib2]). In brief, tissue samples were prepared for immunohistochemistry as described above. After the final PBS wash, samples were fully immersed in a 0.1 mg/mL solution of Acryloyl-X, SE (Thermofisher \#A20770) for four hours at room temperature. Following this, samples were washed three times in 1X PBS for 10 min prior to proceeding with gelation to remove unreacted reagents. To form the hydrophilic gel around the samples, a 47:1:1:1 solution of Stock X (see below): TEMED (0.1 mg/mL, Thermo Fisher \#17919): APS (0.1 mg/mL, Sigma Aldrich \#248614--5G): 4-Hydroxy-TEMPO (5.0 mg/mL, Sigma Aldrich \#176141--1G) was placed within chambers surrounding the tissue slices. Stock X solution was made using the following proportions: 38 grams of sodium acrylate (Sigma Aldrich \#408220--5G), 50 grams of acrylamide (Sigma Aldrich \#A9099-25G), 2 grams of N,N'-Methylenebisacrylamide (Sigma Aldrich \#M7279-25G), and 29.2 grams of sodium chloride (S9888-25G) in a total volume of 100 mL using 10X PBS stock. Slides were then incubated at 4°C for one hour followed by incubation at 37°C for an additional three hours to allow the gel to fully set. Once solidified, slides were trimmed of excess gel and placed into deionized water for one hour. To allow the samples to fully expand, the water bath was exchanged every fifteen minutes with fresh deionized water. Individual gels were then mounted in deep chambers with fresh deionized water surrounding the sample and imaged on an Olympus Fluoview FV1200 confocal microscope and processed using Fiji. For neuron reconstruction, 3D rendered images were generated using Imaris.

In situ hybridization {#s4-4}
---------------------

In situ hybridization was performed by the RNA In Situ Hybridization Core at BCM using an automated robotic platform as previously described ([@bib55]). In brief, we prepared digoxigenin (DIG)-labeled riboprobes using cDNA from E15 and P7 mouse brain RNA using a RNeasy Mini Kit (Qiagen, Germany). DNase treatment was performed to digest genomic DNA. The following LKB1 forward and reverse PCR primers were used to generate cDNA fragments corresponding to the desired ribo-probes: GCGATTTAGGTGACACTATAGCTTTTCAGGTTTCAAGGTGGAC and GCGTAATACGACTCACTATAGGGACCCTCATAGCCATAGCTCAAA. DIG-labeled riboprobes were synthesized using a DIG RNA labeling kit (Roche, Switzerland), diluted in hybridization buffer at a concentration of 100 ng/uL, and stored at −20°C until use.

Eyes were enucleated, and the lens was dissected out. Eyecups were cryoprotected in 30% sucrose, frozen in OCT (VWR), and stored at −80°C before sectioning. Retina cryosections (20 μm) were mounted on Superfrost Plus Slides (VWR). Sections were fixed and acetylated before the hybridization procedure, which was performed on a high-throughput platform. The slides were developed using tyramide labeled with Cy3 directly (TSA-Plus system; Perkin-Elmer Life Sciences, Waltham, MA) for 15 min, followed by staining with 4'−6-diamindino-2-phenlindole (DAPI) before mounting in Prolong Diamond (Invitrogen, Carlsbad, CA).

RNAScope {#s4-5}
--------

To confirm deletion of *Stk11*, RNAScope was performed using RNAscope Probe-Mm-Stk11 (cat. \# 469211) on 20 μm tissue sections collected as described above for immunohistochemistry. After sectioning, 4% paraformaldehyde was applied to each slide for an additional 30 min at room temperature. Fluorescent in situ hybridization (FISH) was performed using the commercially available RNAscope fluorescent multiplex assay according to the manufacturer's instructions (ACDbio, Newark, CA) with the following with minor modifications. Tissue was dehydrated using an ethanol gradient of 10%, 30%, 50%, 70% and 100% (3 minutes each), and the boiling time in target retrieval solution was shortened to 5 min. After FISH, slides were co-stained for calbindin to visualize horizontal cell bodies.

Histological quantification {#s4-6}
---------------------------

All quantification was performed using retinal sections prepared from Lkb1-Ret, Lkb1-HC, and control animals at early postnatal ages (P1, P3, P5, P8). Littermate controls were used in all experiments, and all images were acquired at equivalent retinal eccentricities from the optic nerve head. For all experiments, data were collected from 3 to 8 mice per group, and three to four images per animal were obtained. To quantify the number of ectopic nuclei in the OPL, DAPI was used to label nuclei at P8, and antibodies to rhodopsin (rods) and Chx10 (bipolar cells) were used to demarcate the OPL boundaries. The number of nuclei within the OPL was counted in each image (211.97 × 211.97 µm^2^), and values were averaged. To quantify the number of OPL patches relative to cone terminals and horizontal cell contacts, nuclei were stained with DAPI while cones were stained with anti-OPN1SW. Patches were defined as the location of a cone terminal that coincided with a gap in the nuclear plexus. The distance of both patches and cone terminals were quantified from the apical retina surface as the shortest line that encompassed the apical surface and the top of the OPL patch. To quantify fluorescent intensity for in situ hybridization and synapse-associated proteins, retinal, layer boundaries were manually defined using the corresponding DAPI images. For P5, P8, and P14 retinas, the boundaries of the ONL, OPL, INL, IPL, and GCL were marked. For P1-P3, the ONBL was divided into equal sublayers to allow for more spatial definition of the expression pattern. The relative levels of the signal averaged over three randomly selected regions of the same size within each layer were computed, and a background subtraction was applied to remove background noise. To quantify the number of bipolar cells, cones, and horizontal cells, antibodies against Chx10, OPN1SW, and calbindin were used, respectively. The number of cells within an image (211.97 × 211.97 µm^2^) were counted and values were averaged. To quantify the number of apical neurites per horizontal cell, horizontal cells were stained with an antibody to calbindin. The number of neurites coming from the top half of each horizontal cell soma was counted, and values for each horizontal cell in each image were averaged. To quantify cone axon length, sections were stained with an OPN1SW antibody to label cone photoreceptors. The length of each axon terminal was defined as the shortest line that encompassed the base of the nuclei and the end of the axon terminal. All cones in a z-stack were analyzed. To quantify the levels and location of VGLUT1, sections were stained with an antibody to VGLUT1 and colabeled with OPN1SW to mark cone cell bodies and terminals. A cone with VGLUT1 staining present within the cell body was quantified as a soma VGLUT1 containing cell, while a cell with VGLUT1 staining that overlapped with the terminal was quantified as a terminal VGLUT1 containing cell. To quantify the corrected total cell fluorescence of VGLUT1 in different neuronal compartments, the area of the cell multiplied by the mean fluorescence of background readings was subtracted from the integrated density. The number of horizontal cell contacts made with cones was determined in a single optical section, and the distance of this contact was measured from the end of the horizontal cell neurite to the center of the horizontal cell soma. Contacts with terminals were denoted by horizontal cell neurites overlapping with cone terminals, while contacts with non-terminal regions were denoted by horizontal cell neurites overlapping with either the cone soma, axon shaft, or inner and outer segments. Horizontal cell colocalization with VGLUT1 was determined by examining the overlap between calbindin and VGLUT1. Horizontal contacts with VGLUT1 at neuron terminals were denoted by calbindin positive neurites overlapping with terminal restricted VGLUT1, while contacts with non-terminal regions were denoted by horizontal cell neurites overlapping with VGLUT1 localized in either the cone soma or along the axon shaft. Analysis of RNAscope was conducted by counting *Stk11* positive puncta within horizontal cell bodies across sections where samples were blinded for identity.

Quantification algorithms {#s4-7}
-------------------------

The area of the OPL and horizontal cell terminal restriction were measured using algorithms developed for this purpose in Fiji. All algorithms were validated by manual quantification of representative data sets prior to use. OPL area was measured by selecting the DAPI channel and normalizing the saturation using the normalize equalize function set at 0.3 to remove noise in individual cells. Gaussian blur was then applied with sigma = 5. The image was then converted to binary and inverted to count the empty OPL space using the analyze particles function. For each animal, images of 211.97 × 211.97 µm^2^ from 2 to 4 different locations were included, and for each image 3 individual Z slices at least 3 µm apart were analyzed. All data were then averaged across each sample and converted from pixels to microns before statistical analysis. Horizontal cell terminal restriction was measured in Z stacks that were condensed using the maximum intensity function. Outliers within one radius and over a brightness threshold of 50 were removed. The image was then rotated 90 degrees, and the intensity across each region was summed in bins following alignment to the highest intensity as the center of the restriction. For each animal, images from 2 to 4 different locations were analyzed.

Statistical analysis {#s4-8}
--------------------

Analyses of the number of ectopic nuclei, number of outer retina neurons, OPL area, number of apical neurites per horizontal cells, total number of patches, axon length, number of contacts between horizontal cells and cones or VGLUT1, number of *Stk11* puncta per horizontal cell, and the length of horizontal cell neurites that contact cones were performed using a non-parametric Mann-Whitney Rank Sum U-test. Analyses of the distance of patches from apical surface were performed using an unpaired two-tailed Student's t test. Horizontal cell restriction, VGLUT1 localization and expression, and the position of horizontal cell and cone or VGLUT1 contacts were analyzed using an unpaired t-test across rows, with VGLUT1 quantifications and position of contacts corrected for multiple comparisons using the Holm-Sidak method. Statistical differences were evaluated using GraphPad Prism seven software. p\<0.05 was considered statistically significant.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The manuscript by Burger et al. explores the role of the serine/threonine kinase LKB1 in neuronal remodeling during the development of the mouse retina. The experiments here are well designed and executed, and the manuscript is clearly written. The take-home lesson is that defects in cone extension, caused by an absence of LKB1 in cones in the LKB1RET knockout mice and most obvious at P1-P5, cause defects in synapse localization and HC remodeling. This suggests that in the WT animals, normal cone extension drives HC neurite remodeling.

**Decision letter after peer review:**

\[Editors' note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.\]

Thank you for submitting your work entitled \"LKB1 coordinates neurite remodeling to drive synapse layer emergence in the outer retina\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Senior Editor. The reviewers have opted to remain anonymous. Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

Summary:

As you will see, the reviewers were very interested in role of LKB1 in neurite remodeling in the retina, and the generally high quality of your work. One of the reviewers was generally satisfied with the manuscript. However, the other two reviewers had concerns that focus around the impact of this work compared to your prior paper in 2014; a number of specific technical questions; and concerns with the evidence to support some of your conclusions. In particular, they thought the role of VGlut1 was overstated and would require substantially more evidence, and they were unconvinced by the experiments showing that LKB1 acts non-cell autonomously in horizontal cells. The full original comments of the reviewers are below.

Reviewer \#1:

A very nice study exploring the cellular and molecular mechanisms of synapse and layer formation in the outer mammalian retina. This is an excellent model for parsing these processes more generally. Overall the study appears carefully done and clearly shows a role for LKB1 in horizontal cell neurite restriction and the timing of layer formation.

I have 2 questions that I hope the authors can address in the Discussion or Results.

1\) Do they think (or have evidence for the idea) that horizontal cells are targeting VGLUT1 per se, or their terminals?

2\) Is there anything about the sequence or structure of VGLUT1 that makes this a real possibility? Similar mechanisms have, after all, been observed for L-Type Ca^2+^ channels at NMJs.

Reviewer \#2:

This manuscript by Burger et al. explores the role of the serine/threonine kinase LKB1 in the development of the mouse retina. LKB1 has been previously shown to be important in a number of aspects of neuronal development generally, and has been shown to be widely expressed in retinal cells in aging animals, but LKB1\'s role in the refinement of retinal cell architecture and synapse localization is a novel finding of this manuscript. Overall, the work is generally interesting to the field, though its impact could be improved with some additional experiments.

1\) I am perplexed/alarmed by the many reported p-values of p=0.0286. Specifically Figure 1C is reported as showing a 40.1% reduction in number of patches at P3, p = 0.0286; Figure 2A, B is reported as showing an 85.6% increase in the number of ectopic nuclei at P8, p = 0.0286; Figure 2C, D is reported as showing a 57.8% reduction in total OPL area in um2 at P8, p = 0.0286; and Figure 5H is reported as showing the 3.5% of axons that failed to reach the OPL at P8, p = 0.0286. It seems highly unlikely that all these 4 different measurements of different things, at 2 different developmental stages, would all result in p-values that are exactly identical.

2\) The authors use 2 main Cre lines to knockout LKB1, one that is widely expressed in the retina, and another that is expressed only in the horizontal cells.

2a) The authors conclude that LKB1 is not acting cell-autonomously in the horizontal cells, because the HC knockout mice do not show the same defects as the pan-retinal KO mice (Figure 4). The authors should demonstrate that LKB1 is in fact gone in the HCs in those mice (possibly by immunostaining for LKB1 to show that there is no protein in the HCs in those mice), before they interpret the absence of a phenotype.

2b) Is LKB1 acting cell autonomously in the cones? Is there a Cre line that would KO LKB1 in the cone cells, to demonstrate where LKB1 is functionally required? Based on the temporal sequence of events, it seems like the cone axon extension defects at P1 precede the P5 HC defects, which along with the lack of a phenotype in the LKB1HC mice, would suggest that the cone cells are driving this process. A new mouse line is beyond the existing resources of the manuscript. However, the Introduction suggests that they\'ll demonstrate what cells are driving this refinement process, but in the absence of a cone-specific LKB1 KO mouse, they can\'t really back up that claim.

3\) There are some processes that show defects at P5 which are resolved by P8 in LKB1 mutants, but other defects persist at or past P8. Temporary defects include the HC remodeling from radial to planar morphology (Figure 3), and most of the cone axon extension defects (Figure 5). Persistent defects include the OPL disorganization in OPL area per FOV and rod soma localization in the INL (Figure 2), ectopic contacts between HCs and non-terminal parts of cone cells (Figure 6), and VGLUT1 localization in cone somas (Figure 8). Given that the title claims that LKB1 coordinates these processes, please comment on why LKB1 is necessary for some of these processes but not others, and why some of them but not others can eventually be resolved in the absence of LKB1.

4\) Please explain how you identified where the patches are in Figure 1B-D. Looking by eye, I see a number of patches, both more apical patches in the control and deeper patches in the LBK1RET, that are not labeled with a magenta arrowhead. How did you determine what met the size/shape criteria to be called a patch?

5\) The authors show the mislocalization of VGLUT1 in the Lkb1-Ret KO animals in Figure 8-10, but do not test any other synaptic markers to see if they are also mislocalized. While VGLUT1 may be the only marker that was easily visible at P1, as shown in Figure 7, some of the other markers, including the synapse marker PSD95, are visible at P5, when VGLUT1 mislocalization is still very obvious. Is PSD95 also mislocalized at P5, like VGLUT1, and/or at P8?

Reviewer \#3:

The manuscript by Burger et al. examines the role of the serine/threonine kinase Lkb1 in regulating formation of the outer plexiform layer (OPL) in the retina. Previous work from Dr. Samuel identified a role for the Lkb1-AMPK pathway in synaptic remodeling of horizontal cells in the OPL of the aging retina (Samuel et al., 2014). However, it was unknown if Lkb1 function during the development or maintenance of these retinal neurons and their synapses. The present study addresses this by using conditional deletion of Lkb1 and observing the development of cones, horizontal cells, and their synapses throughout their development. Horizontal cells normal remodel their dendrites from an AP polarity to a lateral one between P3 and P5; this process is delayed in Lkb1 mutants. They nicely show that this is a non-cell autonomous effect that arises due to a delay in cone photoreceptor axon extension towards the nascent OPL. Interestingly, horizontal projections extend into the outer nuclear layer and make ectopic contacts on cone cell bodies and stunted axons in the Lkb1 mutants. These ectopic contact sites co-localize with presynaptic Vglut1, suggesting they may identify synapses.

The authors are commended for the quality of their imaging data and the robust quantification methods employed. In addition, the manuscript is very well written and organized, leading to understandable conclusions. The main issue is whether the findings in this paper are novel enough for publication in *eLife*. The horizontal cell phenotypes observed here are largely the same as what the same group previously reported in older animals. There is not really any new information on the upstream or downstream signals related to Lkb1 that provide insight into its function or how the cone axon extension phenotype arises. In addition, Lkb1 has previously been shown to have a role in axon extension, so the delay in cone axon growth in the retina is not entirely unexpected. While the notion that cone axon contacts may be important for horizontal dendrites to remodel from AP to lateral projections is interesting, it is not entirely unprecedented: horizontal dendrite remodeling frequently occurs in response to photoreceptor axon retraction in a number of contexts. Finally, in the Discussion the authors seem to imply that Vglut1 mislocalization (in cones) may play a key role in the horizontal cell phenotypes (subsection "Defective VGLUT1 localization in LKB1 mutant mice"), going as far as to suggest that \"Vglut1 may act as a contact guidance cue\". However, they do not have any data that directly support this idea. Isn\'t it just as likely that the ectopic horizontal contacts on cones recruit presynaptic receptors and associated scaffolding proteins that could result in the ectopic Vglut1 localization in cones?

There are a few other points for consideration:

1\) Have the authors looked at mosaic arrangement of horizontal cells and cones in the Lkb1 mutants? Do the defects in the Lkb1 mutants lead to uneven axon/dendrite coverage in the OPL plexus?

2\) In Figure 3E, can the authors quantify the frequency of ectopic horizontal cell projections in Lkb1 mutants at P8?

3\) Lkb1 mutants show a delayed axon extension from the cone photoreceptors; is this just an axon phenotype, or are cone outer segments also delayed in the Lkb1 mutants?

10.7554/eLife.56931.sa2

Author response

\[Editors' note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors' response to the first round of review.\]

> Summary:
>
> As you will see, the reviewers were very interested in role of LKB1 in neurite remodeling in the retina, and the generally high quality of your work. One of the reviewers was generally satisfied with the manuscript. However, the other two reviewers had concerns that focus around the impact of this work compared to your prior paper in 2014; a number of specific technical questions; and concerns with the evidence to support some of your conclusions. In particular, they thought the role of VGlut1 was overstated and would require substantially more evidence, and they were unconvinced by the experiments showing that LKB1 acts non-cell autonomously in horizontal cells. The full original comments of the reviewers are below.

Summary responses to primary concerns:

1\) Impact of this work relative to previous data.

Several key distinctions set this work apart from our previous data and that of the field. First, it is impactful because we demonstrate a defined molecular process that links pre and postsynaptic neuron structure to synapse formation. Second, we show that synapse layer emergence differs from synapse decline in three important ways: (i) it involves unique cellular processes; (ii) it employs different neurons and synapses; and (iii) it utilizes distinct downstream molecular pathways. We explain these points below.

a\) We directly link neuron structure to synapse formation. The relationship between the structure and location of neuron development and precise synapse formation has remained opaque in most systems. This is because many neurons form a large number of synapses, and these synapses are broadly distributed along the neuron. In the retina, we can precisely interrogate the relationship between presynaptic structure, postsynaptic refinement, and synapse emergence. We use this organization and leverage LKB1 induced changes in neuron shape to show that cone axon extension and synapse protein localization coordinately regulates post-synaptic neuron refinement and synapse emergence.

b\) Synapse formation involves district cellular processes. This study focuses on how neurons acquire their paired shapes and connectivity, not how they lose them. We show here that synapse emergence and decline involve fundamentally different cellular attributes and drivers. Horizontal cells provide an excellent example of this difference. In development, these neurons need to arrive, mature, and then transform from a widely dispersed migrating cell into a highly lateralized neuron with a dendrite and an axon. In aging, horizontal cells dendrite are unaffected, while axons that were happily lateralized for \~2 years begin to extend neurites (Samuel et al., 2014). Thus, developmental *refinement* is biologically distinct from the *confinement* defects observed in aging.

c\) Synapse layer emergence is driven by different presynaptic neurons than synapse aging. We show here that synapse emergence in retina involves cone-horizontal interactions. In contrast, aging is driven by rods. Cone and rod synapses have vastly different structures and even laminate in distinct regions of the OPL. It has long been a mystery what sets up synaptic organization at this first synapse in vision, and we shed light on that important problem here.

d\) Molecular drivers of synapse emergence differ from drivers of synapse aging. In aging, LKB1 functions in rods via AMPK while cones are unaltered (Samuel et al., 2014). We now show that developmental synapse emergence is independent of AMPK (Figure 1---figure supplement 2). These data support the idea that aging cannot simply be viewed as a 'reversal of development' even when similar upstream molecules are involved. In our view, this is a strength of our manuscript. It should also be noted that in aging LKB1 signaling does not impact synaptic protein localization, as it does in development. This again supports the idea that the mechanisms differ.

2\) Overstating the role of VGLUT1. Thanks for this comment, and we apologize if our data were overinterpreted. This was not our intent. We agree with the reviewers that we cannot conclude from this data alone that VGLUT1 drives this process. We have revised our language accordingly. In addition, since submission we also have collected additional data regarding other synaptic protein defects, which we have included in the revised manuscript.

First, we've now shown that other synapse proteins are altered in cone terminal localization in addition to VGLUT1, and generally show low levels in LKB1 mutants relative to controls (Figure 7). Notably, however, unlike VGLUT1, these other synapse proteins are not present at high levels even in control animals until at or after OPL emergence and therefore would be unlikely to drive alterations in cone-horizontal cell contacts.

Second, we have conducted expansion microscopy to highlight differences in levels and location of Ribeye as a representative additional synapse component (Figure 8).

3\) Unconvinced of the role of LKB1 in horizontal cells. To confirm that LKB1 is indeed missing from horizontal cells in the LKB1F/F:Cx57iCre animals, we have conducted preliminary RNAscope for LKB1 in this line together with staining for horizontal cells and include this data here (Figure 4---figure supplement 1). These data support that LKB1 transcript levels are decreased in LKB1F/F: Cx57iCre horizontal cells, and we would be happy to provide additional quantitative analysis. Previous papers have also confirmed that Cx57iCre is active by P2, before horizontal cell defects are observed (Barasso et al., 2018).

> Reviewer \#1:
>
> \[...\] I have 2 questions that I hope the authors can address in the Discussion or Results.
>
> 1\) Do they think (or have evidence for the idea) that horizontal cells are targeting VGLUT1 per se, or their terminals?

Given that VGLUT1 is mislocalized in cone photoreceptors, we quantified the number of terminal and non-terminal contacts that horizontal cells make onto cones. Of those at non-terminal contacts, we then quantified those that contacted mislocalized VGLUT1. Nearly all mistargeted horizontal processes made contacts with ectopic VGLUT1 locations (Figure 10). However, we agree that this is supportive but not direct evidence that VGLUT1 (which is the primary transporter for glutamate in cones) regulates the location of cone-horizontal cell contacts. As noted above, we will be happy to revise our language accordingly. However, since submission we also have collected additional data to bolster the role of VGLUT1 in this process, which we would also be happy to include in a revised manuscript. First, we've now shown that other synapse proteins are altered in cone terminal localization in addition to VGLUT1, and generally show low levels in LKB1 mutants relative to controls. Notably, however, unlike VGLUT1, these other synapse proteins are not present at high levels even in control animals until at or after OPL emergence and therefore would be unlikely to drive alterations in cone-horizontal cell contacts (Figure 7). Second, we have conducted expansion microscopy to highlight differences in levels and location of Ribeye as a representative additional synapse component (Figure 8).

> 2\) Is there anything about the sequence or structure of VGLUT1 that makes this a real possibility? Similar mechanisms have, after all, been observed for L-Type Ca^2+^ channels at NMJs.

Thank you for this comment. Indeed, similar mechanisms are involved with L-type calcium channels in synapse formation at the NMJ. Loss of these channels results in loss of acetycholine receptor patterning as well as excessive nerve branching and failure of axons to recognize postsynaptic targets (Kaplan et al., 2018; Kaplan and Flucher, 2019). This will be a good point to address in the Discussion. Given that VGLUT1 is a transporter found on synaptic vesicles, it itself is unlikely directly involved with targeting, but rather glutamate signaling could be a driver of the phenotypes that we observe, just as calcium at the NMJ regulates similar processes.

> Reviewer \#2:
>
> \[...\] Overall, the work is generally interesting to the field, though its impact could be improved with some additional experiments.
>
> 1\) I am perplexed/alarmed by the many reported p-values of p=0.0286. Specifically Figure 1C is reported as showing a 40.1% reduction in number of patches at P3, p = 0.0286; Figure 2A, B is reported as showing an 85.6% increase in the number of ectopic nuclei at P8, p = 0.0286; Figure 2C, D is reported as showing a 57.8% reduction in total OPL area in um2 at P8, p = 0.0286; and Figure 5H is reported as showing the 3.5% of axons that failed to reach the OPL at P8, p = 0.0286. It seems highly unlikely that all these 4 different measurements of different things, at 2 different developmental stages, would all result in p-values that are exactly identical.

The reviewer is correct that there were several P-values that were similar. We have double checked our numbers and our statistical methods and find the reported numbers to be accurate with one exception, where the correct calculated value is 0.0294. We used the Mann-Whitney Rank-Sum test in Prism6 to determine the significance of differences quantified, given that we cannot assume a normal distribution of the data. We also employed an in-house biostatistician to verify our calculations in R.

> 2\) The authors use 2 main Cre lines to knockout LKB1, one that is widely expressed in the retina, and another that is expressed only in the horizontal cells.
>
> 2a) The authors conclude that LKB1 is not acting cell-autonomously in the horizontal cells, because the HC knockout mice do not show the same defects as the pan-retinal KO mice (Figure 4). The authors should demonstrate that LKB1 is in fact gone in the HCs in those mice (possibly by immunostaining for LKB1 to show that there is no protein in the HCs in those mice), before they interpret the absence of a phenotype.

Previous papers have confirmed that Cx57iCre is active by P2, before horizontal cell defects are observed (Barasso et al., 2018). To confirm the loss of LKB1 in these cells, we have conducted preliminary RNA-scope for LKB1 in this line together with staining for horizontal cells and include this data here (Figure 4---figure supplement 1). These data suggest that LKB1 transcripts are absent from horizontal cells in these mice. Unfortunately, IHC for LKB1 is not possible due to lack of compatible antibodies (we've tested five so far). We would also be happy to perform a time course analysis of Cx57iCre; Ai14 expression to show when the Cre is active and how many cells it effects.

> 2b) Is LKB1 acting cell autonomously in the cones? Is there a Cre line that would KO LKB1 in the cone cells, to demonstrate where LKB1 is functionally required? Based on the temporal sequence of events, it seems like the cone axon extension defects at P1 precede the P5 HC defects, which along with the lack of a phenotype in the LKB1HC mice, would suggest that the cone cells are driving this process. A new mouse line is beyond the existing resources of the manuscript. However, the Introduction suggests that they\'ll demonstrate what cells are driving this refinement process, but in the absence of a cone-specific LKB1 KO mouse, they can\'t really back up that claim.

Deleting LKB1 from cones early in development is a challenge given the available resources. We have considered 4 approaches in good faith but none are suitable. The first is a mouse line. The only Cone-specific cre that has been widely used is HRGP-Cre. We have this line, but unfortunately the Cre is not active until P8, after OPL emergence has occurred. A second approach is electroporation, but this too spares cones because cones are done dividing by birth and therefore do not receive the constructs (Sarin et al., 2018). Third, we have tried electroporation at E15 but find that GFP dilutes out in subsequent cell divisions, making it difficult to discern what cells our electroporation targeted. Finally, we have considered injecting AAV. However, given that AAV takes 21 days for full expression we are unable to visualize transduction by P5 even if viruses are injected early.

> 3\) There are some processes that show defects at P5 which are resolved by P8 in LKB1 mutants, but other defects persist at or past P8. Temporary defects include the HC remodeling from radial to planar morphology (Figure 3), and most of the cone axon extension defects (Figure 5). Persistent defects include the OPL disorganization in OPL area per FOV and rod soma localization in the INL (Figure 2), ectopic contacts between HCs and non-terminal parts of cone cells (Figure 6), and VGLUT1 localization in cone somas (Figure 8). Given that the title claims that LKB1 coordinates these processes, please comment on why LKB1 is necessary for some of these processes but not others, and why some of them but not others can eventually be resolved in the absence of LKB1.

We thank the reviewer for these comments. While many defects are still present at P8, cone axons have largely extended (though their final length is shorter than controls) so there appear to be some redundant mechanisms at play here. However, it is worth noting that this does not mean that the circuit is functioning normally. Indeed, we've shown that adult LKB1 mutants display defective rod and cone visual signaling (Samuel et al., 2014).

> 4\) Please explain how you identified where the patches are in Figure 1B-D. Looking by eye, I see a number of patches, both more apical patches in the control and deeper patches in the LBK1RET, that are not labeled with a magenta arrowhead. How did you determine what met the size/shape criteria to be called a patch?

We appreciate this suggestion, and we would be happy to clarify how patches are delineated. To define a patch, we asked whether a gap in the nuclear stain overlapped with the location of either a horizontal cell terminal, a cone terminal, or both, since the neurites of these cells are first to form contacts in development. The gaps to which the reviewers refer are caused by horizontal cell soma and do not reflect points of contact. We have now clarified how patches were identified and quantified in the text (subsections "Cone axon extension and maturation are disrupted in LKB1 mutant mice" and "LKB1 is required for early localization of VGLUT1).

> 5\) The authors show the mislocalization of VGLUT1 in the LKB1RET KO animals in Figure 8-10, but do not test any other synaptic markers to see if they are also mislocalized. While VGLUT1 may be the only marker that was easily visible at P1, as shown in Figure 7, some of the other markers, including the synapse marker PSD95, are visible at P5, when VGLUT1 mislocalization is still very obvious. Is PSD95 also mislocalized at P5, like VGLUT1, and/or at P8?

We have included in this revised manuscript additional data on other synapse proteins in LKB1 mutants (Figure 7). We show that other synapse proteins are indeed altered in their localization to the cone terminal. To illustrate this, we have completed additional expansion microscopy showing differences in levels and location of Ribeye (Figure 8). Notably, however, unlike VGLUT1, these other synapse proteins are present at or after OPL emergence so are unlikely to contribute to OPL formation.

> Reviewer \#3:
>
> \[...\] The authors are commended for the quality of their imaging data and the robust quantification methods employed. In addition, the manuscript is very well written and organized, leading to understandable conclusions. The main issue is whether the findings in this paper are novel enough for publication in eLife. The horizontal cell phenotypes observed here are largely the same as what the same group previously reported in older animals. There is not really any new information on the upstream or downstream signals related to Lkb1 that provide insight into its function or how the cone axon extension phenotype arises. In addition, Lkb1 has previously been shown to have a role in axon extension, so the delay in cone axon growth in the retina is not entirely unexpected. While the notion that cone axon contacts may be important for horizontal dendrites to remodel from AP to lateral projections is interesting, it is not entirely unprecedented: horizontal dendrite remodeling frequently occurs in response to photoreceptor axon retraction in a number of contexts.

We thank the reviewer for these comments and apologize that we did not make the distinction clearer between our previous work and this manuscript. In fact, they are different at the cellular, synaptic, and molecular level. We have clarified these points in the section above entitled "Impact of this work relative to previous data".

> Finally, in the Discussion the authors seem to imply that Vglut1 mislocalization (in cones) may play a key role in the horizontal cell phenotypes (subsection "Defective VGLUT1 localization in LKB1 mutant mice"), going as far as to suggest that \"Vglut1 may act as a contact guidance cue\". However, they do not have any data that directly support this idea. Isn\'t it just as likely that the ectopic horizontal contacts on cones recruit presynaptic receptors and associated scaffolding proteins that could result in the ectopic Vglut1 localization in cones?

Please refer to point 3 in our general responses above. It was not our intent to overstate our findings and agree with the reviewers that we cannot conclude from this data alone that VGLUT1 drives this process (though it may indeed contribute). We will be happy to revise our language accordingly. However, since submission we also have collected additional data, which we would be happy to include in a revised manuscript. First, we've now shown that other synapse proteins are altered in cone terminal localization in addition to VGLUT1, and generally show low levels in LKB1 mutants relative to controls. Notably, however, unlike VGLUT1, these other synapse proteins are not present at high levels even in control animals until at or after OPL emergence and therefore would be unlikely to drive alterations in cone- horizontal cell contacts (Figure 7). Second, we have conducted expansion microscopy to highlight differences in levels and location of Ribeye as a representative additional synapse component (Figure 8).

> There are a few other points for consideration:
>
> 1\) Have the authors looked at mosaic arrangement of horizontal cells and cones in the Lkb1 mutants? Do the defects in the Lkb1 mutants lead to uneven axon/dendrite coverage in the OPL plexus?

Thank you for this suggestion. We have examined mosaic spacing in the LKB1 mutants and see no difference in spacing or OPL coverage ([Author response image 1](#respfig1){ref-type="fig"}).

![](elife-56931-resp-fig1){#respfig1}

2\) In Figure 3E, can the authors quantify the frequency of ectopic horizontal cell projections in Lkb1 mutants at P8?Thank you for this suggestion. We have provided quantifications as [Author response image 2](#respfig2){ref-type="fig"} but would be happy to include this data as a supplementary figure if deemed necessary.

![](elife-56931-resp-fig2){#respfig2}

3\) Lkb1 mutants show a delayed axon extension from the cone photoreceptors; is this just an axon phenotype, or are cone outer segments also delayed in the Lkb1 mutants?Cone outer segments appear normal during development. They can be observed in Figure 5.
